Latest News about AWKNF
Recent news which mentions AWKNF
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
March 02, 2023
Tickers
AWKNF
From Benzinga
Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California
March 02, 2023
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
From Benzinga
Awakn's First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics
February 22, 2023
Tickers
AWKNF
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
From Benzinga
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
February 14, 2023
From Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
February 13, 2023
From Benzinga
Awakn's Ketamine Treatment For Alcohol Use Disorder Awarded UK's Fast-Track Status
February 07, 2023
Tickers
AWKNF
From Benzinga
Two New Studies On Classical Psychedelics: Grading Ketamine's Components, Tuning Down Psilocybin Dosing
January 24, 2023
Tickers
AWKNF
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
From Benzinga
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
December 19, 2022
From Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
From Benzinga
Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic
December 03, 2022
Tickers
AWKNF
From Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
November 29, 2022
From Benzinga
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest
November 23, 2022
Tickers
AWKNF
From Benzinga
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
November 15, 2022
From Benzinga
EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC
November 09, 2022
From Benzinga
Can Ketamine Treat Alcohol Addiction? In-Clinic Therapy Vs. Retreats
October 13, 2022
Tickers
AWKNF
From Benzinga
Can Ketamine Treat Alcohol Addiction? The Awakn Approach
October 10, 2022
Tickers
AWKNF
From Benzinga
Can Ketamine Treat Alcohol Addiction? Clinics & Hospitals In Europe And North America Are Already Doing It
September 30, 2022
Tickers
AWKNF
From Benzinga
Awakn And Catalent's Partnership Could Provide Hope For People Suffering From Addiction
September 26, 2022
From Benzinga
Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year
September 17, 2022
Tickers
AWKNF
From Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
September 13, 2022
From Benzinga
Psychedelics Companies Seek Innovative Methods To Deliver Assisted Therapies, This One Stands Out
September 12, 2022
Tickers
AWKNF
From Benzinga
Most, But Not All, Psychedelics Companies Have Sufficient Liquidity
September 06, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.